SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CollPlant Holdings Ltd. – ‘6-K’ for 6/26/18

On:  Tuesday, 6/26/18, at 6:05am ET   ·   For:  6/26/18   ·   Accession #:  1213900-18-8198   ·   File #:  1-38370

Previous ‘6-K’:  ‘6-K’ on / for 6/25/18   ·   Next:  ‘6-K’ on / for 7/5/18   ·   Latest:  ‘6-K’ on / for 4/4/24   ·   1 Reference:  By:  CollPlant Biotechnologies Ltd. – ‘424B5’ on 2/16/21

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/26/18  CollPlant Holdings Ltd.           6-K         6/26/18    2:47K                                    Edgar Agents LLC/FA

Current Report by a Foreign Private Issuer   —   Form 6-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Report of Foreign Private Issuer                    HTML     11K 
 2: EX-99.1     Press Release, Dated June 26, 2018                  HTML     12K 


6-K   —   Report of Foreign Private Issuer


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of June 2018

Commission File Number 001-38370

 

CollPlant Holdings Ltd.

(Exact name of registrant as specified in its charter)

 

3 Sapir Street, Weizmann Science Park

Ness Ziona 74140, Israel

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒          Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7): ☐

 

 

 

 C: 

 

 

 

Attached hereto as Exhibit 99.1 and incorporated by reference herein is a press release issued by the Registrant entitled “CollPlant Receives Research and Development Project Approval from the Israel Innovation Authority to Advance its Collagen-Based BioInk for 3D Printing of Tissues and Organs”.

 

Exhibit    
     
99.1   Press Release, dated June 26, 2018.

 

 C: 

 C: 1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  COLLPLANT HOLDINGS LTD.
     
Date: June 26, 2018 By: /s/ Eran Rotem
    Name: Eran Rotem
    Title:   Deputy CEO and
Chief Financial Officer

 

 

2

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘6-K’ Filing    Date    Other Filings
Filed on / For Period End:6/26/18None on these Dates
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/21  CollPlant Biotechnologies Ltd.    424B5                  1:566K                                   EdgarAgents LLC/FA
Top
Filing Submission 0001213900-18-008198   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 6:18:10.1pm ET